{"organizations": [], "uuid": "fd6162c59891265961d8a9cdeaa839b523dffdce", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pieris-pharmaceuticals-and-seattle/brief-pieris-pharmaceuticals-and-seattle-genetics-announce-multi-program-immuno-oncology-collaboration-idUSFWN1PZ0W5", "country": "US", "domain_rank": 408, "title": "BRIEF-Pieris Pharmaceuticals And Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-09T13:47:00.000+02:00", "replies_count": 0, "uuid": "fd6162c59891265961d8a9cdeaa839b523dffdce"}, "author": "", "url": "https://www.reuters.com/article/brief-pieris-pharmaceuticals-and-seattle/brief-pieris-pharmaceuticals-and-seattle-genetics-announce-multi-program-immuno-oncology-collaboration-idUSFWN1PZ0W5", "ord_in_thread": 0, "title": "BRIEF-Pieris Pharmaceuticals And Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration", "locations": [], "entities": {"persons": [], "locations": [{"name": "seattle", "sentiment": "none"}], "organizations": [{"name": "seattle genetics announce multi-program immuno-oncology collaboration", "sentiment": "negative"}, {"name": "brief-pieris pharmaceuticals and seattle genetics announce multi-prog", "sentiment": "negative"}, {"name": "immuno-oncology collaboration reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "pieris pharmaceuticals inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 52 AM / Updated 8 minutes ago BRIEF-Pieris Pharmaceuticals And Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration Reuters Staff 1 Min Read \nFeb 9 (Reuters) - Pieris Pharmaceuticals Inc: \n* PIERIS PHARMACEUTICALS AND SEATTLE GENETICS ANNOUNCE MULTI-PROGRAM IMMUNO-ONCOLOGY COLLABORATION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-09T13:47:00.000+02:00", "crawled": "2018-02-09T14:04:39.001+02:00", "highlightTitle": ""}